Please login to the form below

Not currently logged in
Email:
Password:

ABPI toolkit to help pharma companies disclose trial data

Aims to improve transparency efforts in UK

ABPI London offices

Pharma companies in the UK now have access to a set of guidelines on how to disclose trial data from clinical studies in order to fit transparency requirements.

The toolkit from trade body the Association of the British Pharmaceutical Industry (ABPI) comes in the wake of growing calls for improved access to trial data in order to better assess the effectiveness of drugs in an independent manner.

This campaign has been led by AllTrials - a group that has received backing from organisations such as NICE, IQWIG and even GlaxoSmithKline (GSK), but has been dismissed by the ABPI as “PR-driven initiative”, with the trade body claiming to have had plans to improve transparency long before AllTrials was launched.

It seems that the industry is on its way to greater access to data in some form, after commitments from the European Federation of Pharmaceutical Industries and Associations (EFPIA) and plans in place from the European Medicines Agency (EMA), although there is still great debate on this can be implemented.

The ABPI toolkit is designed to improve the transparency process based on current guidance and follows a commitment made in February 2013 to improve compliance through the use of an independent third party to monitor member companies and report infractions to UK pharma's self-regulatory body the Prescription Medicines Code of Practice Authority (PMCPA).

The clinical trial disclosure toolkit expands on that by proving guidance in 11 areas, including good practice guidelines, disclosure checklists and template standard operating procedure.

Specific topics include the registrations of clinical trials with the European database EudraCT as well as a definition of constitutes the sort of patient level data that research organisations need access to for meta-analysis.

“These documents are intended as an additional support to guide companies of all sizes through the different steps of the disclosure process,” said the ABPI.

Read the ABPI clinical trial disclosure toolkit

 

Article by
Thomas Meek

15th August 2013

From: Research, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics